Asset Allocation

As of November 30, 2025.
Type % Net
Cash 0.03%
Stock 49.93%
Bond 27.42%
Convertible 0.00%
Preferred 0.00%
Other 22.62%
View Asset Allocation
Start Trial

Market Capitalization

Large --
Mid --
Small --
No Data Available
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 77.29%    % Emerging Markets: 0.00%    % Unidentified Markets: 22.71%

Americas 76.14%
76.09%
Canada 0.02%
United States 76.07%
0.04%
As of November 30, 2025. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 1.10%
United Kingdom 0.22%
0.88%
France 0.00%
Ireland 0.68%
Netherlands 0.04%
Sweden 0.00%
Switzerland 0.15%
0.00%
0.00%
Saudi Arabia 0.00%
United Arab Emirates 0.00%
Greater Asia 0.05%
Japan 0.00%
0.00%
Australia 0.00%
0.05%
Singapore 0.05%
0.00%
Unidentified Region 22.71%

Bond Credit Quality Exposure

AAA 0.00%
AA 20.55%
A 0.00%
BBB 0.00%
BB 0.00%
B 0.00%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.00%
Not Available 79.45%
Short Term 0.00%
As of November 30, 2025
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
14.61%
Materials
0.91%
Consumer Discretionary
5.64%
Financials
7.08%
Real Estate
0.99%
Sensitive
30.43%
Communication Services
5.80%
Energy
1.54%
Industrials
4.21%
Information Technology
18.89%
Defensive
9.13%
Consumer Staples
2.55%
Health Care
5.29%
Utilities
1.28%
Not Classified
45.83%
Non Classified Equity
0.03%
Not Classified - Non Equity
45.80%
As of November 30, 2025
View Region Exposure
Start Trial

Bond Sector Exposure

As of November 30, 2025
Type % Net
Government 99.99%
Corporate 0.01%
Securitized 0.00%
Municipal 0.00%
Other 0.00%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
92.24%
Less than 1 Year
92.24%
Intermediate
7.76%
1 to 3 Years
7.76%
3 to 5 Years
0.00%
5 to 10 Years
0.00%
Long Term
0.00%
10 to 20 Years
0.00%
20 to 30 Years
0.00%
Over 30 Years
0.00%
Other
0.00%
As of November 30, 2025
View Bond Maturity Exposure
Start Trial